Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
Details for 2022180831
Up to date per 04.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2022180831
Title / Product Name
RSV-IMMUNISIERUNGSTHERAPIE
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2022180831
EP Publication Number
4144368
E-Number
1770013
Language
EN
PCT Number
Publication Date
08.03.2023 A
26.02.2025 B1
Registration Date
26.02.2025
AT Publication Date
15.03.2025
Application Date
26.01.2012
Registration Number
-
Priorities
26.01.2011
US
201161436355 P
IPC
A61K 39/12 20060101AFI20230201BHEP
Maximum Duration of Protection
26.01.2032
Owner
GlaxoSmithKline Biologicals S.A.
Rue de l'Institut, 89
1330 Rixensart
BE
Representative
No representatives present
Inventor
DORMITZER, Philip, R.
Emeryville, CA 94662-8097
US